Drug therapy justified for ‘morning sickness’?
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
1999 |
|---|---|
| Erschienen: |
1999 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Drugs & therapy perspectives - 14(1999), 9 vom: Okt., Seite 10-13 |
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Bodyweight Loss |
|---|
| doi: |
10.2165/00042310-199914090-00004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2037824424 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2037824424 | ||
| 003 | DE-627 | ||
| 005 | 20230508074713.0 | ||
| 007 | tu | ||
| 008 | 200819s1999 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.2165/00042310-199914090-00004 |2 doi | |
| 035 | |a (DE-627)OLC2037824424 | ||
| 035 | |a (DE-He213)00042310-199914090-00004-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q AVZ |
| 084 | |a PHARM |2 fid | ||
| 245 | 1 | 0 | |a Drug therapy justified for ‘morning sickness’? |
| 264 | 1 | |c 1999 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 650 | 4 | |a Thyroid Stimulate Hormone |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Cleft Palate |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Hyperemesis Gravidarum |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Bodyweight Loss |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Patient Care Guideline |7 (dpeaa)DE-He213 | |
| 773 | 0 | 8 | |i Enthalten in |t Drugs & therapy perspectives |d Auckland : Wolters Kluwer Health Adis, 1993 |g 14(1999), 9 vom: Okt., Seite 10-13 |w (DE-627)182320197 |w (DE-600)1197107-1 |w (DE-576)090827716 |x 1172-0360 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:1999 |g number:9 |g month:10 |g pages:10-13 |
| 856 | 4 | 1 | |u https://doi.org/10.2165/00042310-199914090-00004 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PSY | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 1999 |e 9 |c 10 |h 10-13 | ||